Meet the scientists and engineers behind Panther's pioneering venture. The experienced and accomplished management team combines deep industry knowledge with a passion for innovation.

CEO and Co-Founder

CTO and UX

Formulation and Manufacturing

Device and IP

Formulation Engineer
Lawson is a scientific leader and innovator with extensive experience in biomedical engineering, drug delivery systems, and materials science. Previously, as a doctoral researcher at Carnegie Mellon University, he spearheaded the development of novel nanoscale metal-organic frameworks (MOFs) for the encapsulation and intracellular delivery of mRNA and other nucleic acids, driving advancements in gene therapy and thermally stable vaccine storage. He earned a Ph.D. in Chemical Engineering from Carnegie Mellon University and a B.S. in Chemical Engineering from the University of Pittsburgh.

VP, People and Operations
Talie is a dynamic, business-oriented Human Resources leader with over a decade of experience scaling organizations through critical stages of growth. She thrives in fast-paced startup environments, building People functions from the ground up and designing programs that attract, retain and develop high-performing teams. Her professional experience spans diverse and complex industries. Prior to joining Panther, Talie served as Chief People Officer at CoinDesk, where she scaled the company over six years and led it through a successful acquisition. Talie holds a Bachelor of Science in Policy Analysis and Management from Cornell University.

Formulation Engineer
Muhammad Sohaib Khan is a scientific leader with expertise in microneedle array patch (MAP) technology, vaccines, and biologics development. As a founding research leader at GAPHAS Pharmaceutical Inc., he advanced dissolvable MAP formulations toward preclinical readiness, optimizing polymer matrices, antigen design, dissolution profiles, and GMP-compatible processes with a focus on vaccine delivery. At Galapagos NV, he led CAR-T and antibody discovery programs. He earned a Ph.D. in Infectious Diseases & Microbiology from the University of Pittsburgh and a B.S. in Biology from Bridgewater College.

Process Development Engineer
Rachael is a Process Development Engineer at Panther Life Sciences, where she scales microneedle array patch (MAP) technologies from pilot to commercial manufacturing. She works across process design, optimization, and scale-up to enable next-generation drug delivery platforms. She holds a B.S. in Chemical Engineering from Bucknell University, where she was a Presidential Fellow focused on polymer-based drug delivery research. She is passionate about bridging innovation to bring effective treatments closer to patients.

Co-founder
Anne has over 25 years of experience across drug discovery and development — spanning small molecules, monoclonal antibodies and immunotherapies — holding an AB in Biology from Harvard and a Ph.D. from UC Berkeley. Anne has a strong track record in leadership, intellectual property, and strategic planning. A proven early-stage operator, she has been part of the founding or pre-public teams at multiple companies, demonstrating the versatility and adaptability essential for high-growth startup environments.



